Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Archive
- 2024/Volume 45
- 2023/Volume 44
- 2022/Volume 43
- 2021/Volume 42
- 2020/Volume 41
- 2019/Volume 40
- 2018/Volume 39
- 2017/Volume 38
- 2016/Volume 37
- 2015/Volume 36
- 2014/Volume 35
- 2013/Volume 34
- 2012/Volume 33
- 2011/Volume 32
- 2011/Volume 31
- 2009/Volume 30
- 2008/Volume 29
- 2007/Volume 28
- 2006/Volume 27
- 2005/Volume 26
- 2004/Volume 25
- 2003/Volume 24
- 2002/Volume 23
- 2001/Volume 22
- 2000/Volume 21
Immunotherapy for Gynecological Oncology
Deadline for manuscript submissions: 31 July 2021
Print Special Issue Flyer (4)Special Issue Editor
Guest Editor
Tadahiro Shoji, MDE-MailWebsite
Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Japan
Interests: Ovarian Cancer
Special Issue Information
Dear Colleagues,
In recent years, immunotherapy has been studied as a promising candidate for being the "fourth pillar" in the treatment of gynecological cancer. Unfortunately, however, no cancer vaccine therapy targeting tumor-specific antigens has yet been approved in any field, including the field of gynecological cancer, and progress in the development of such therapies has been slow. In contrast, recently developed immune checkpoint inhibitors, such as anti-cytotoxic T-lymphocyte antigen 4 antibodies and anti-programmed cell death 1 antibodies, have attracted attention because of their dramatic and long-term antitumor effects and have vitalized the development of cancer immunotherapies.
The response rates to immune checkpoint inhibitors are estimated to be up to 30% for melanoma and approximately 10%–20% for other types of cancer, except for Hodgkin's lymphoma. These drugs are expensive and may cause autoimmune adverse events. Future issues related to immune checkpoint inhibitor therapy include the selection of responders, identification of biomarkers useful for determining the optimal treatment duration and other treatment details in responders, and development of therapies for patients who do not respond to immune checkpoint inhibitors.
At present, in the field of gynecology, studies are being conducted to evaluate combinations of multiple cancer immunotherapies and combinations of cancer immunotherapy with chemotherapy, molecular-targeted drugs, or other treatments. Furthermore, personalized peptide vaccine therapy and personalized T-cell transfer therapy based on tumor-specific mutant antigens have been studied in some cancer types and histological types associated with various gene mutations. Thus, cancer immunotherapy can be regarded as a promising therapy in the field of gynecology.
The aim of this special issue of the Journal is to collect new insights on this fascinating topic.
Prof. Dr. Tadahiro Shoji
Guest Editor
Keywords
Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Manuscript Submission Information
Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access journal published by MRE Press. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.
Share This Special Issue
Published Papers (2 papers)
Treatment strategies for ovarian cancer focusing on prostaglandins
Treatment strategies for ovarian cancer focusing on prostaglandins
DOI: 10.31083/j.ejgo4205148
(This article belongs to the Special Issue Immunotherapy for Gynecological Oncology)
Characteristics of microsatellite instability-high gynecologic cancer and efficacy of pembrolizumab: a single-institution experience
Characteristics of microsatellite instability-high gynecologic cancer and efficacy of pembrolizumab: a single-institution experience
DOI: 10.31083/j.ejgo4204113
(This article belongs to the Special Issue Immunotherapy for Gynecological Oncology)
Abstracted / indexed in
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.
Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.
JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.
Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.
BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.